{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T12:33:01Z","timestamp":1793277181824,"version":"4.5.0"},"reference-count":94,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100008250","name":"Feinberg School of Medicine","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008250","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012007","name":"Rockefeller University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012007","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacionline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Allergy and Clinical Immunology"],"published-print":{"date-parts":[[2021,7]]},"DOI":"10.1016\/j.jaci.2021.01.001","type":"journal-article","created":{"date-parts":[[2021,1,14]],"date-time":"2021-01-14T02:02:34Z","timestamp":1610589754000},"page":"148-163","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":167,"title":["The molecular features of normal and atopic dermatitis skin in infants, children, adolescents, and adults"],"prefix":"10.1016","volume":"148","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2876-3048","authenticated-orcid":false,"given":"Yael","family":"Renert-Yuval","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ester","family":"Del Duca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana B.","family":"Pavel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Milie","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel","family":"Lefferdink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianni","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aisleen","family":"Diaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yeriel D.","family":"Estrada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Talia","family":"Canter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ning","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annette","family":"Wagner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Chamlin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James G.","family":"Krueger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma","family":"Guttman-Yassky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy S.","family":"Paller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaci.2021.01.001_bib1","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.det.2017.02.002","article-title":"Public health burden and epidemiology of atopic dermatitis","volume":"35","author":"Silverberg","year":"2017","journal-title":"Dermatol Clin"},{"key":"10.1016\/j.jaci.2021.01.001_bib2","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1111\/1346-8138.15048","article-title":"Burden of atopic dermatitis in Asia","volume":"46","author":"Tsai","year":"2019","journal-title":"J Dermatol"},{"key":"10.1016\/j.jaci.2021.01.001_bib3","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1016\/j.jaci.2016.07.013","article-title":"Early-onset pediatric atopic dermatitis is TH2 but also TH17 polarized in skin","volume":"138","author":"Esaki","year":"2016","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2021.01.001_bib4","doi-asserted-by":"crossref","first-page":"2094","DOI":"10.1016\/j.jaci.2018.02.040","article-title":"Early-onset pediatric atopic dermatitis is characterized by TH2\/TH17\/TH22-centered inflammation and lipid alterations","volume":"141","author":"Brunner","year":"2018","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2021.01.001_bib5","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.jaci.2019.09.031","article-title":"Evolution of pathologic T-cell subsets in patients with atopic dermatitis from infancy to adulthood","volume":"145","author":"Czarnowicki","year":"2020","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2021.01.001_bib6","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1111\/1346-8138.13392","article-title":"Clinical Practice Guidelines for the Management of Atopic Dermatitis 2016","volume":"43","author":"Saeki","year":"2016","journal-title":"J Dermatol"},{"key":"10.1016\/j.jaci.2021.01.001_bib7","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.anai.2017.09.055","article-title":"Immunologic, microbial, and epithelial interactions in atopic dermatitis","volume":"120","author":"Brunner","year":"2018","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaci.2021.01.001_bib8","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1097\/ACI.0000000000000455","article-title":"Monoclonal antibodies for the treatment of atopic dermatitis","volume":"18","author":"Renert-Yuval","year":"2018","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2021.01.001_bib9","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1016\/j.jaci.2019.01.003","article-title":"Report from the National Institute of Allergy and Infectious Diseases workshop on \u201cAtopic dermatitis and the atopic march: Mechanisms and interventions\u201d","volume":"143","author":"Davidson","year":"2019","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2021.01.001_bib10","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1080\/14656566.2018.1561868","article-title":"An update on the topical and oral therapy options for treating pediatric atopic dermatitis","volume":"20","author":"Glines","year":"2019","journal-title":"Expert Opin Pharmacother"},{"key":"10.1016\/j.jaci.2021.01.001_bib11","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1111\/bjd.16156","volume":"178","author":"de Bruin-Weller","year":"2018","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaci.2021.01.001_bib12","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.jaci.2018.08.022","article-title":"Dupilumab progressively improves systemic and cutaneous abnormalities in atopic dermatitis patients","volume":"143","author":"Guttman-Yassky","year":"2019","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2021.01.001_bib13","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.det.2018.12.007","article-title":"What\u2019s new in atopic dermatitis","volume":"37","author":"Renert-Yuval","year":"2019","journal-title":"Dermatol Clin"},{"key":"10.1016\/j.jaci.2021.01.001_bib14","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1111\/bjd.18476","article-title":"Dupilumab in adolescents with uncontrolled moderate-to-severe atopic dermatitis: results from a phase IIa open-label trial and subsequent phase III open-label extension","volume":"182","author":"Cork","year":"2020","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaci.2021.01.001_bib15","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1001\/jamadermatol.2019.3336","article-title":"Efficacy and safety of dupilumab in adolescents with uncontrolled moderate to severe atopic dermatitis: a phase 3 randomized clinical trial","volume":"156","author":"Simpson","year":"2020","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.jaci.2021.01.001_bib16","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.jamcollsurg.2012.06.004","article-title":"When is death inevitable after emergency laparotomy? Analysis of the American College of Surgeons National Surgical Quality Improvement Program database","volume":"215","author":"Al-Temimi","year":"2012","journal-title":"J Am Coll Surg"},{"key":"10.1016\/j.jaci.2021.01.001_bib17","first-page":"123","article-title":"Evaluation of skin barrier function in allergic contact dermatitis and atopic dermatitis using method of the continuous TEWL measurement","volume":"48","author":"Laudanska","year":"2003","journal-title":"Rocz Akad Med Bialymst"},{"key":"10.1016\/j.jaci.2021.01.001_bib18","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1016\/j.jaci.2015.06.032","article-title":"Alopecia areata profiling shows TH1, TH2, and IL-23 cytokine activation\u00a0without parallel TH17\/TH22 skewing","volume":"136","author":"Suarez-Farinas","year":"2015","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2021.01.001_bib19","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/j.jaci.2011.05.042","article-title":"Reversal of atopic dermatitis with narrow-band UVB phototherapy and biomarkers for therapeutic response","volume":"128","author":"Tintle","year":"2011","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2021.01.001_bib20","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1016\/j.jaci.2010.12.1124","article-title":"Nonlesional atopic dermatitis skin is characterized by broad terminal differentiation defects and variable immune abnormalities","volume":"127","author":"Suarez-Farinas","year":"2011","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2021.01.001_bib21","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1186\/s13073-016-0384-y","article-title":"XGR software for enhanced interpretation of genomic summary data, illustrated by application to immunological traits","volume":"8","author":"Fang","year":"2016","journal-title":"Genome Med"},{"key":"10.1016\/j.jaci.2021.01.001_bib22","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.jaci.2014.03.009","article-title":"Molecular profiling of contact dermatitis skin identifies allergen-dependent differences in immune response","volume":"134","author":"Dhingra","year":"2014","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2021.01.001_bib23","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.jaci.2015.11.001","article-title":"Extensive alopecia areata is reversed by IL-12\/IL-23p40 cytokine antagonism","volume":"137","author":"Guttman-Yassky","year":"2016","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2021.01.001_bib24","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/s12920-015-0133-x","article-title":"Meta-analysis derived atopic dermatitis (MADAD) transcriptome defines a robust AD signature highlighting the involvement of atherosclerosis and lipid metabolism pathways","volume":"8","author":"Ewald","year":"2015","journal-title":"BMC Med Genomics"},{"key":"10.1016\/j.jaci.2021.01.001_bib25","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.jaip.2014.03.006","article-title":"Skin barrier and immune dysregulation in atopic dermatitis: an evolving story with important clinical implications","volume":"2","author":"Czarnowicki","year":"2014","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaci.2021.01.001_bib26","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1016\/j.jaci.2012.07.012","article-title":"Progressive activation of T(H)2\/T(H)22 cytokines and selective epidermal proteins characterizes acute and chronic atopic dermatitis","volume":"130","author":"Gittler","year":"2012","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2021.01.001_bib27","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.semcdb.2016.09.005","article-title":"SERPINB3 and B4: from biochemistry to biology","volume":"62","author":"Sun","year":"2017","journal-title":"Semin Cell Dev Biol"},{"key":"10.1016\/j.jaci.2021.01.001_bib28","doi-asserted-by":"crossref","first-page":"2110","DOI":"10.1016\/j.jid.2017.05.004","article-title":"Tapinarof is a natural AhR agonist that resolves skin inflammation in mice and humans","volume":"137","author":"Smith","year":"2017","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaci.2021.01.001_bib29","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.jdermsci.2014.02.009","article-title":"Distribution of IL-31 and its receptor expressing cells in skin of atopic dermatitis","volume":"74","author":"Kato","year":"2014","journal-title":"J Dermatol Sci"},{"key":"10.1016\/j.jaci.2021.01.001_bib30","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.3389\/fphys.2019.01514","article-title":"Interleukin-5 in the pathophysiology of severe asthma","volume":"10","author":"Pelaia","year":"2019","journal-title":"Front Physiol"},{"key":"10.1016\/j.jaci.2021.01.001_bib31","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1111\/all.14196","article-title":"TSLP and IL-33 reciprocally promote each other\u2019s lung protein expression and ILC2 receptor expression to enhance innate type-2 airway inflammation","volume":"75","author":"Toki","year":"2020","journal-title":"Allergy"},{"key":"10.1016\/j.jaci.2021.01.001_bib32","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.immuni.2006.06.015","article-title":"CXCR4 physically associates with the T cell receptor to signal in T cells","volume":"25","author":"Kumar","year":"2006","journal-title":"Immunity"},{"key":"10.1016\/j.jaci.2021.01.001_bib33","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/S0091-6749(98)70282-9","article-title":"Association of increased CD4+ T-cell infiltration with increased IL-16 gene expression in atopic dermatitis","volume":"102","author":"Laberge","year":"1998","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2021.01.001_bib34","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1001\/jamadermatol.2019.2983","article-title":"Use of tape strips to detect immune and barrier abnormalities in the skin of children with early-onset atopic dermatitis","volume":"155","author":"Guttman-Yassky","year":"2019","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.jaci.2021.01.001_bib35","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.anai.2018.08.024","article-title":"Atopic dermatitis in African American patients is TH2\/TH22-skewed with TH1\/TH17 attenuation","volume":"122","author":"Sanyal","year":"2019","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaci.2021.01.001_bib36","doi-asserted-by":"crossref","first-page":"14755","DOI":"10.1074\/jbc.M500025200","article-title":"Identification of two novel human acyl-CoA wax alcohol acyltransferases: members of the diacylglycerol acyltransferase 2 (DGAT2) gene superfamily","volume":"280","author":"Turkish","year":"2005","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jaci.2021.01.001_bib37","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1038\/s10038-019-0711-4","article-title":"Identification of a CDH12 potential candidate genetic variant for an autosomal dominant form of transgrediens and progrediens palmoplantar keratoderma in a Tunisian family","volume":"65","author":"Charfeddine","year":"2020","journal-title":"J Hum Genet"},{"key":"10.1016\/j.jaci.2021.01.001_bib38","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/j.jaci.2010.10.018","article-title":"Tight junction defects in patients with atopic dermatitis","volume":"127","author":"De Benedetto","year":"2011","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2021.01.001_bib39","doi-asserted-by":"crossref","DOI":"10.1080\/21688370.2018.1539596","article-title":"The role of microtubules in the regulation of epithelial junctions","volume":"6","author":"Vasileva","year":"2018","journal-title":"Tissue Barriers"},{"key":"10.1016\/j.jaci.2021.01.001_bib40","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1111\/exd.13272","article-title":"Phylogenetic profiling and gene expression studies implicate a primary role of PSORS1C2 in terminal differentiation of keratinocytes","volume":"26","author":"Abbas Zadeh","year":"2017","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.jaci.2021.01.001_bib41","first-page":"11","article-title":"Rosiglitazone inhibits HMC-1 cell migration and adhesion through a peroxisome proliferator-activated receptor gamma-dependent mechanism","volume":"13","author":"Zhang","year":"2014","journal-title":"Iran J Allergy Asthma Immunol"},{"key":"10.1016\/j.jaci.2021.01.001_bib42","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1084\/jem.20051701","article-title":"Cholesterol deficiency in a mouse model of Smith-Lemli-Opitz syndrome reveals increased mast cell responsiveness","volume":"203","author":"Kovarova","year":"2006","journal-title":"J Exp Med"},{"key":"10.1016\/j.jaci.2021.01.001_bib43","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.jdermsci.2013.02.003","article-title":"Adapalene suppresses sebum accumulation via the inhibition of triacylglycerol biosynthesis and perilipin expression in differentiated hamster sebocytes in\u00a0vitro","volume":"70","author":"Sato","year":"2013","journal-title":"J Dermatol Sci"},{"key":"10.1016\/j.jaci.2021.01.001_bib44","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1016\/j.bbalip.2017.06.009","article-title":"Control of lipid droplet fusion and growth by CIDE family proteins","volume":"1862","author":"Gao","year":"2017","journal-title":"Biochim Biophys Acta Mol Cell Biol Lipids"},{"key":"10.1016\/j.jaci.2021.01.001_bib45","first-page":"138","article-title":"Leptin and atopic dermatitis in Korean elementary school children","volume":"15","author":"Seo","year":"2016","journal-title":"Iran J Allergy Asthma Immunol"},{"key":"10.1016\/j.jaci.2021.01.001_bib46","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1016\/j.jid.2018.01.036","article-title":"Neutralization of IL-17C reduces skin inflammation in mouse models of psoriasis and atopic dermatitis","volume":"138","author":"Vandeghinste","year":"2018","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaci.2021.01.001_bib47","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1016\/j.jid.2018.02.037","article-title":"IL-17C: a unique epithelial cytokine with potential for targeting across the spectrum of atopic dermatitis and psoriasis","volume":"138","author":"Guttman-Yassky","year":"2018","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaci.2021.01.001_bib48","first-page":"359","article-title":"Inside out or outside in: does atopic dermatitis disrupt barrier function or does disruption of barrier function trigger atopic dermatitis?","volume":"96","author":"Silverberg","year":"2015","journal-title":"Cutis"},{"key":"10.1016\/j.jaci.2021.01.001_bib49","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1056\/NEJMoa1314768","article-title":"Dupilumab treatment in adults with moderate-to-severe atopic dermatitis","volume":"371","author":"Beck","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaci.2021.01.001_bib50","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.jaci.2012.08.002","article-title":"IL-33, but not thymic stromal lymphopoietin or IL-25, is central to mite\u00a0and peanut allergic sensitization","volume":"131","author":"Chu","year":"2013","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2021.01.001_bib51","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1016\/j.jaci.2014.06.032","article-title":"IL-9 is a key component of memory TH cell peanut-specific responses from children with peanut allergy","volume":"134","author":"Brough","year":"2014","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2021.01.001_bib52","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1111\/imr.12619","article-title":"Interleukin-33 (IL-33): a nuclear cytokine from the IL-1 family","volume":"281","author":"Cayrol","year":"2018","journal-title":"Immunol Rev"},{"key":"10.1016\/j.jaci.2021.01.001_bib53","doi-asserted-by":"crossref","first-page":"2295","DOI":"10.1016\/j.jid.2018.09.001","article-title":"Research techniques made simple: transepidermal water loss measurement as a research tool","volume":"138","author":"Alexander","year":"2018","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaci.2021.01.001_bib54","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1016\/j.jaci.2009.03.041","article-title":"IL-22-producing \u201cT22\u201d T cells account for upregulated IL-22 in atopic dermatitis despite reduced IL-17-producing TH17 T cells","volume":"123","author":"Nograles","year":"2009","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2021.01.001_bib55","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1111\/j.1398-9995.2010.02361.x","article-title":"Stratum corneum TARC level is a new indicator of lesional skin inflammation in atopic dermatitis","volume":"65","author":"Morita","year":"2010","journal-title":"Allergy"},{"key":"10.1016\/j.jaci.2021.01.001_bib56","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1111\/j.1365-2249.2005.02875.x","article-title":"Interleukin-4 and interleukin-13 enhance CCL26 production in a human keratinocyte cell line, HaCaT cells","volume":"141","author":"Kagami","year":"2005","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.jaci.2021.01.001_bib57","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1084\/jem.20051135","article-title":"TSLP-activated dendritic cells induce an inflammatory T helper type 2 cell response through OX40 ligand","volume":"202","author":"Ito","year":"2005","journal-title":"J Exp Med"},{"key":"10.1016\/j.jaci.2021.01.001_bib58","doi-asserted-by":"crossref","first-page":"707","DOI":"10.4049\/jimmunol.1602185","article-title":"IL-17 receptor A\u00a0maintains and protects the skin barrier to prevent allergic skin inflammation","volume":"199","author":"Floudas","year":"2017","journal-title":"J Immunol"},{"key":"10.1016\/j.jaci.2021.01.001_bib59","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1111\/j.1399-3038.2007.00692.x","article-title":"Serum levels of Th2 chemokines, CCL17, CCL22, and CCL27, were the important markers of severity in infantile atopic dermatitis","volume":"19","author":"Nakazato","year":"2008","journal-title":"Pediatr Allergy Immunol"},{"key":"10.1016\/j.jaci.2021.01.001_bib60","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/S1081-1206(10)60170-6","article-title":"Expansion of FOXP3-positive CD4+CD25+ T cells associated with disease activity in atopic dermatitis","volume":"103","author":"Ito","year":"2009","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaci.2021.01.001_bib61","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1038\/mi.2017.10","article-title":"Intelectin contributes to allergen-induced IL-25, IL-33, and TSLP expression and type 2 response in asthma and atopic dermatitis","volume":"10","author":"Yi","year":"2017","journal-title":"Mucosal Immunol"},{"key":"10.1016\/j.jaci.2021.01.001_bib62","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.jaci.2019.01.015","article-title":"Age-specific changes in the molecular phenotype of patients with moderate-to-severe atopic dermatitis","volume":"144","author":"Zhou","year":"2019","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2021.01.001_bib63","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/s12948-017-0077-0","article-title":"Immunosenescence in aging: between immune cells depletion and cytokines up-regulation","volume":"15","author":"Ventura","year":"2017","journal-title":"Clin Mol Allergy"},{"key":"10.1016\/j.jaci.2021.01.001_bib64","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1146\/annurev.med.51.1.245","article-title":"Age-associated increased interleukin-6 gene expression, late-life diseases, and frailty","volume":"51","author":"Ershler","year":"2000","journal-title":"Annu Rev Med"},{"key":"10.1016\/j.jaci.2021.01.001_bib65","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/S0531-5565(00)00220-5","article-title":"Serum interleukin-6, soluble interleukin-6 receptor and soluble gp130 exhibit different patterns of age- and menopause-related changes","volume":"36","author":"Giuliani","year":"2001","journal-title":"Exp Gerontol"},{"key":"10.1016\/j.jaci.2021.01.001_bib66","doi-asserted-by":"crossref","first-page":"6912","DOI":"10.4049\/jimmunol.178.11.6912","article-title":"Altered innate immune functioning of dendritic cells in elderly humans: a role of phosphoinositide 3-kinase-signaling pathway","volume":"178","author":"Agrawal","year":"2007","journal-title":"J Immunol"},{"key":"10.1016\/j.jaci.2021.01.001_bib67","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1016\/j.jaci.2017.10.032","article-title":"Enhancement of cutaneous immunity during aging by blocking p38 mitogen-activated protein (MAP) kinase-induced inflammation","volume":"142","author":"Vukmanovic-Stejic","year":"2018","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2021.01.001_bib68","article-title":"Evolution of the immune system in humans from infancy to old age","volume":"282","author":"Simon","year":"2015","journal-title":"Proc Biol Sci"},{"key":"10.1016\/j.jaci.2021.01.001_bib69","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1126\/science.1196509","article-title":"Fetal and adult hematopoietic stem cells give rise to distinct T cell lineages in humans","volume":"330","author":"Mold","year":"2010","journal-title":"Science"},{"key":"10.1016\/j.jaci.2021.01.001_bib70","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1002\/eji.201141847","article-title":"Developmental regulation of Th17-cell capacity in human neonates","volume":"42","author":"Black","year":"2012","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.jaci.2021.01.001_bib71","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.3389\/fimmu.2020.01640","article-title":"Children from the age of three show a developmental switch in T-cell differentiation","volume":"11","author":"Knolle","year":"2020","journal-title":"Front Immunol"},{"key":"10.1016\/j.jaci.2021.01.001_bib72","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2019.109705","article-title":"The role of IL-37 in skin and connective tissue diseases","volume":"122","author":"Pan","year":"2020","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.jaci.2021.01.001_bib73","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.jaci.2014.10.037","article-title":"Identification of novel immune and barrier genes in atopic dermatitis by means of laser capture microdissection","volume":"135","author":"Esaki","year":"2015","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2021.01.001_bib74","doi-asserted-by":"crossref","first-page":"6329","DOI":"10.1038\/ncomms7329","article-title":"TGF-beta3-expressing CD4+CD25(\u2212)LAG3+ regulatory T cells control humoral immune responses","volume":"6","author":"Okamura","year":"2015","journal-title":"Nat Commun"},{"key":"10.1016\/j.jaci.2021.01.001_bib75","first-page":"29","article-title":"Overview of LAG-3-expressing, IL-10-producing regulatory T cells","volume":"410","author":"Fujio","year":"2017","journal-title":"Curr Top Microbiol Immunol"},{"key":"10.1016\/j.jaci.2021.01.001_bib76","doi-asserted-by":"crossref","first-page":"S59","DOI":"10.1016\/S0140-6736(15)60374-9","article-title":"Characteristics of immunosuppressive regulatory T cells in cutaneous squamous cell carcinomas and role in metastasis","volume":"385","author":"Lai","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.jaci.2021.01.001_bib77","doi-asserted-by":"crossref","first-page":"4079","DOI":"10.4049\/jimmunol.1201061","article-title":"Blockade of IL-10 signaling during bacillus Calmette-Guerin vaccination enhances and sustains Th1, Th17, and innate lymphoid IFN-gamma and IL-17 responses and increases protection to Mycobacterium tuberculosis infection","volume":"189","author":"Pitt","year":"2012","journal-title":"J Immunol"},{"key":"10.1016\/j.jaci.2021.01.001_bib78","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/328146","article-title":"IL-34 suppresses Candida albicans induced TNFalpha production in M1 macrophages by downregulating expression of Dectin-1 and TLR2","volume":"2015","author":"Xu","year":"2015","journal-title":"J Immunol Res"},{"key":"10.1016\/j.jaci.2021.01.001_bib79","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.jaci.2019.09.031","article-title":"Evolution of pathologic T-cell subsets in atopic dermatitis from infancy to adulthood","volume":"145","author":"Czarnowicki","year":"2020","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2021.01.001_bib80","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1016\/j.jaci.2009.03.030","article-title":"TH17 cells and regulatory T cells in primary immunodeficiency diseases","volume":"123","author":"Ochs","year":"2009","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2021.01.001_bib81","doi-asserted-by":"crossref","first-page":"S6","DOI":"10.1016\/j.sder.2012.08.001","article-title":"Current issues in atopic comorbidities and preventing the atopic march","volume":"31","author":"Simpson","year":"2012","journal-title":"Semin Cutan Med Surg"},{"key":"10.1016\/j.jaci.2021.01.001_bib82","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.molimm.2014.06.018","article-title":"The role of the IL-33\/IL-1RL1 axis in mast cell and basophil activation in allergic disorders","volume":"63","author":"Saluja","year":"2015","journal-title":"Mol Immunol"},{"key":"10.1016\/j.jaci.2021.01.001_bib83","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1038\/s41590-018-0112-4","article-title":"CARD9(S12N) facilitates the production of IL-5 by alveolar macrophages for the induction of type 2 immune responses","volume":"19","author":"Xu","year":"2018","journal-title":"Nat Immunol"},{"key":"10.1016\/j.jaci.2021.01.001_bib84","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1007\/s00408-017-0058-6","article-title":"IL-8 gene variants and expression in childhood asthma","volume":"195","author":"Charrad","year":"2017","journal-title":"Lung"},{"key":"10.1016\/j.jaci.2021.01.001_bib85","doi-asserted-by":"crossref","first-page":"151","DOI":"10.2332\/allergolint.13-RAI-0564","article-title":"New insights into atopic dermatitis: role of skin barrier and immune dysregulation","volume":"62","author":"Leung","year":"2013","journal-title":"Allergol Int"},{"key":"10.1016\/j.jaci.2021.01.001_bib86","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.jaci.2005.10.033","article-title":"IL-31: a new link between T cells and pruritus in atopic skin inflammation","volume":"117","author":"Sonkoly","year":"2006","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2021.01.001_bib87","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1038\/ni1084","article-title":"Interleukin 31, a cytokine produced by activated T cells, induces dermatitis in mice","volume":"5","author":"Dillon","year":"2004","journal-title":"Nat Immunol"},{"key":"10.1016\/j.jaci.2021.01.001_bib88","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.clim.2007.11.006","article-title":"Loricrin and involucrin expression is down-regulated by Th2 cytokines through STAT-6","volume":"126","author":"Kim","year":"2008","journal-title":"Clin Immunol"},{"key":"10.1016\/j.jaci.2021.01.001_bib89","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/j.jaci.2014.08.008","article-title":"Deciphering the complexities of atopic dermatitis: shifting paradigms in treatment approaches","volume":"134","author":"Leung","year":"2014","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2021.01.001_bib90","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.jaci.2011.10.042","article-title":"IL-31 regulates differentiation and filaggrin expression in human organotypic skin models","volume":"129","author":"Cornelissen","year":"2012","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2021.01.001_bib91","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1016\/j.jaci.2018.03.018","article-title":"Nemolizumab in patients with moderate-to-severe atopic dermatitis: randomized, phase II, long-term extension study","volume":"142","author":"Kabashima","year":"2018","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2021.01.001_bib92","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1111\/1346-8138.14934","article-title":"Nemolizumab in moderate to severe atopic dermatitis: an exploratory analysis of work productivity and activity impairment in a randomized phase II study","volume":"46","author":"Mihara","year":"2019","journal-title":"J Dermatol"},{"key":"10.1016\/j.jaci.2021.01.001_bib93","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1016\/j.jaad.2018.01.017","article-title":"Efficacy and safety of lebrikizumab (an anti-IL-13 monoclonal antibody) in adults with moderate-to-severe atopic dermatitis inadequately controlled by topical corticosteroids: a randomized, placebo-controlled phase II trial (TREBLE)","volume":"78","author":"Simpson","year":"2018","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaci.2021.01.001_bib94","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.jaci.2018.05.029","article-title":"Treatment of atopic dermatitis with tralokinumab, an anti-IL-13 mAb","volume":"143","author":"Wollenberg","year":"2019","journal-title":"J Allergy Clin Immunol"}],"container-title":["Journal of Allergy and Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674921000075?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674921000075?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T09:32:08Z","timestamp":1758792728000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0091674921000075"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7]]},"references-count":94,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,7]]}},"alternative-id":["S0091674921000075"],"URL":"https:\/\/doi.org\/10.1016\/j.jaci.2021.01.001","relation":{},"ISSN":["0091-6749"],"issn-type":[{"value":"0091-6749","type":"print"}],"subject":[],"published":{"date-parts":[[2021,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The molecular features of normal and atopic dermatitis skin in infants, children, adolescents, and adults","name":"articletitle","label":"Article Title"},{"value":"Journal of Allergy and Clinical Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaci.2021.01.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 American Academy of Allergy, Asthma & Immunology","name":"copyright","label":"Copyright"}]}}